References
1. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis.Lancet . 2008;372(9647):1411-1426. doi:10.1016/S0140-6736(08)61588-3
2. Iolascon A, Andolfo I, Barcellini W, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica . 2017;102(8):1304-1313. doi:10.3324/haematol.2016.161166
3. Bolton-Maggs PHB, Langer JC, Iolascon A, Tittensor P, King MJ. Guidelines for the diagnosis and management of hereditary spherocytosis - 2011 update. Br J Haematol . 2012;156(1):37-49. doi:10.1111/j.1365-2141.2011.08921.x
4. Smedema JP, Louw VJ. Pulmonary arterial hypertension after splenectomy for hereditary spherocytosis. Cardiovasc J Afr . 2007;18(2):84-89.
5. Pratl B, Benesch M, Lackner H, et al. Partial splenic embolization in children with hereditary spherocytosis. Eur J Haematol . 2008;80(1):76-80. doi:10.1111/j.1600-0609.2007.00979.x
6. Kimura F, Ito H, Shimizu H, et al. Partial Splenic Embolization for the Treatment of Hereditary Spherocytosis. Am J Roentgenol . 2003;181(4):1021-1024. doi:10.2214/ajr.181.4.1811021
7. Maddison F E. Embolic Therapy of Hypersplenism.pdf. Invest Radiol . 1973;8(4):280-281.
8. Spigos D, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. Am J Roentgenol . 1979;132(5):777-782. doi:10.2214/ajr.132.5.777
9. Tussiwand R, Bosco N, Ceredig R, Rolink AG. Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol . 2009;39(9):2317-2324. doi:10.1002/eji.200939633
10. Walport MJ. Complement. First of two parts. N Engl J Med . 2001;344(14):1058-1066. doi:10.1056/NEJM200104053441406
11. Walport MJ. Advances in immunology: Complement (second of two parts). N Engl J Med . 2001;344(15):1140-114. doi:10.1056/NEJM200104123441506
12. Perkins LA, Jones SF, Bhargava RS. Dural venous thrombosis following splenectomy in a patient with hereditary spherocytosis. South Med J . 2009;102(5):542-545. doi:10.1097/SMJ.0b013e31819e90b5
13. Davidsen C, Larsen TH, Gerdts E, Lønnebakken MT. Giant right ventricular outflow tract thrombus in hereditary spherocytosis: A case report. Thromb J . 2016;14(1). doi:10.1186/s12959-016-0083-3
14. Cai M, Huang W, Lin C, et al. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol . 2016;26(2):370-380. doi:10.1007/s00330-015-3839-4
15. Masada T, Tanaka T, Sakaguchi H, et al. Coils versus gelatin particles with or without intraarterial antibiotics for partial splenic embolization: A comparative evaluation. J Vasc Interv Radiol . 2014;25(6):852-858. doi:10.1016/j.jvir.2013.12.563
16. Mackenzie FAF, Elliot DH, Eastcott HHG, Bakkhan P, Mollison PL. RELAPSE IN HEREDITARY SPHEROCYTOSIS WITH PROVEN SPLENUNCULUS.Lancet . 1962;279(7239):1102-1104. doi:10.1016/S0140-6736(62)92084-6
17. De Buys Roessingh AS, De Lagausie P, Rohrlich P, Berrebi D, Aigrain Y. Follow-up of partial splenectomy in children with hereditary spherocytosis. J Pediatr Surg . 2002;37(10):1459-1463. doi:10.1053/jpsu.2002.35412
18. Rice HE, Oldham KT, Hillery CA, Skinner MA, O’Hara SM, Ware RE. Clinical and Hematologic Benefits of Partial Splenectomy for Congenital Hemolytic Anemias in Children. Ann Surg . 2003;237(2):281-288. doi:10.1097/01.SLA.0000048453.61168.8F
19. Bader-Meunier B, Gauthier F, Archambaud F, et al. Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood . 2001;97(2):399-403. doi:10.1182/blood.V97.2.399